Preliminary results of raltitrexed in Chinese patients with metastatic colorectal cancer: A prospective, multicenter, real-world study.

被引：0
|
作者：
Li, Jin
Qin, Shukui
Zhou, Ai-Ping
Zhang, Yanqiao
Yuan, Xianglin
Qin, Baoli
Zeng, Shan
Shen, Lin
Yuan, Ying
Zhu, Liangjun
Wang, Weibo
Zhang, Xianwen
Liang, Jun
Ye, Feng
Chen, Ping
Wang, Huaizhang
Yu, Zhengyan
Fang, Yong
Yue, Lu
Xiong, Jianping
机构：
[1] Shanghai East Hosp, Dept Oncol, Shanghai, Peoples R China
[2] Nanjing Univ Chinese Med, Jinling Hosp, Nanjing, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Clin Res Ctr Canc, Dept Med Oncol,Natl Canc Ctr, Beijing, Peoples R China
[4] Harbin Med Univ, Affiliated Canc Hosp, Harbin, Peoples R China
[5] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Oncol, Wuhan, Peoples R China
[6] Liaoning Canc Hosp & Inst, Shenyang, Peoples R China
[7] Cent South Univ, Dept Oncol, Xiangya Hosp, Changsha, Peoples R China
[8] Peking Univ Canc Hosp & Inst, Minist Educ Beijing, Key Lab Carcinogenesis & Translat Res, Dept Gastrointestinal Oncol, Beijing, Peoples R China
[9] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Med Oncol, Hangzhou, Peoples R China
[10] Jiangsu Canc Hosp, Nanjing, Peoples R China
[11] Shandong Shengli Hosp, Jinan, Peoples R China
[12] Subei Peoples Hosp, Yangzhou, Peoples R China
[13] Peking Univ, Int Hosp, Beijing, Peoples R China
[14] Xiamen Univ, Affiliated Hosp 1, Xiamen, Peoples R China
[15] Ningxia Med Univ, Gen Hosp, Yinchuan, Peoples R China
[16] Mudanjiang Canc Hosp, Mudanjiang, Peoples R China
[17] ZheJiang Univ, Sir Run Run Shaw Hosp, Internal Med Oncol, Sch Med, Hangzhou, Peoples R China
[18] Qingdao Univ, Med Coll, Affiliated Hosp, Dept Oncol, Qingdao, Peoples R China
[19] Nanchang Univ, Affiliated Hosp 1, Dept Oncol, Nanchang, Jiangxi, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3591
引用
收藏
页数：1
相关论文
共 50 条
  • [41] PROSPECTIVE, MULTICENTER STUDY OF APATINIB IN TREATING GYNECOLOGICAL CANCER PATIENTS: A REAL-WORLD STUDY FROM CHINA
    Shi, H.
    Cheng, H.
    Wang, L.
    Wang, Y.
    Jia, Y.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A166 - A167
  • [42] Real-world effectiveness of regorafenib in the treatment of patients with metastatic colorectal cancer: A retrospective, observational study
    Wang, Hailing
    Liu, Weiling
    Zhao, Yan
    Hu, Hongtao
    Zhang, Bin
    Yang, Shujun
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (05) : E291 - E299
  • [43] Classification of patients with metastatic colorectal cancer into consensus molecular subtypes into real-world: A pilot study
    Gonzalez-Montero, Jaime
    Burotto, Mauricio
    Valenzuela, Guillermo
    Mateluna, Debora
    Buen-Abad, Florencia
    Toro, Jessica
    Barajas, Olga
    Marcelain, Katherine
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2023, 14 (10): : 409 - 419
  • [44] Real-world fusion landscape in advanced Chinese gastric cancer using next generation sequencing: A multicenter study.
    Lin, Rongbo
    Zhao, Shen
    Cai, Lisheng
    Chen, Shaoqin
    Lai, Jinhuo
    Fang, Yong
    Cai, Xiuyu
    Wang, Liping
    Fang, Mei-yu
    Xu, Chunwei
    Lin, Li
    Li, Penquan
    Xu, Qi
    Fang, Xuefeng
    Yu, Genhua
    Shan, Jianzhen
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [45] Real-World Outcomes in Patients with Metastatic Colorectal Cancer in Spain: The RWD-ACROSS Study
    Pericay, Carles
    Fernandez Montes, Ana
    Alonso Orduna, Vicente
    Macias Declara, Ismael
    Asensio Martinez, Elena
    Rodriguez Salas, Nuria
    Torres, Esperanza
    Cacho Lavin, Diego
    Rodriguez Alonso, Rosa Maria
    Falco, Esther
    Oliva, Joan Carles
    Cirera, Lluis
    CANCERS, 2023, 15 (18)
  • [46] Quality of life in a real-world study of patients with metastatic colorectal cancer treated with trifluridine/tipiracil
    Cheung, W. Y.
    Kavan, P.
    Dolley, A.
    CURRENT ONCOLOGY, 2020, 27 (05) : E451 - E458
  • [47] Large-Scale, Prospective Observational Study of Regorafenib in Japanese Patients with Metastatic Colorectal Cancer in a Real-World Clinical Setting
    Yamaguchi, Kensei
    Komatsu, Yoshito
    Satoh, Taroh
    Uetake, Hiroyuki
    Yoshino, Takayuki
    Nishida, Toshirou
    Yamazaki, Naoya
    Takikawa, Haiime
    Morimoto, Takashi
    Chosa, Masayuki
    Sunaya, Toshiyuki
    Hamada, Yoko
    Muro, Kei
    Sugihara, Kenichi
    ONCOLOGIST, 2019, 24 (07): : E450 - E457
  • [48] Efficacy and safety of raltitrexed plus S-1 versus regorafenib in patients with refractory metastatic colorectal cancer: a real-world propensity score matching study
    Zhou, Yu-Wen
    Wang, Jia-Ling
    Li, Qing-Fang
    He, Yuan-Lin
    Li, Lin-Juan
    Liu, Rui-Zhi
    Chen, Ye
    Zhang, Shuang
    Qiu, Meng
    Liu, Ji-Yan
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
  • [49] Real-world efficacy and safety of pyrotinib in patients with HER2-positive metastatic breast cancer: A prospective real-world study
    Zhang, Qiongwen
    He, Ping
    Tian, Tinglun
    Yan, Xi
    Huang, Juan
    Zhang, Zhang
    Zheng, Hong
    Zhong, Xiaorong
    Luo, Ting
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [50] Trifluridine/tipiracil or regorafenib in refractory metastatic colorectal cancer patients: An AGEO prospective "real life" study.
    Coutzac, Clelia
    Trouilloud, Isabelle
    Artru, Pascal
    Henriques, Julie
    Masson, Therese
    De La Fouchardiere, Christelle
    Doat, Solene
    Bouche, Olivier
    Coriat, Romain
    Saint, Angelique
    Moulin, Valerie
    Vernerey, Dewi
    Tougeron, David
    Taieb, Julien
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345